Global Sumatriptan Succinate Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Summary

According to APO Research, The global Sumatriptan Succinate market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Sumatriptan Succinate is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Sumatriptan Succinate is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Sumatriptan Succinate is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Sumatriptan Succinate is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Sumatriptan Succinate include Teva, Merck, Mylan, Pfizer, Sun Pharmaceutical, GlaxoSmithKline and Endo Pharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Sumatriptan Succinate, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Sumatriptan Succinate, also provides the sales of main regions and countries. Of the upcoming market potential for Sumatriptan Succinate, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Sumatriptan Succinate sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Sumatriptan Succinate market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Sumatriptan Succinate sales, projected growth trends, production technology, application and end-user industry.


Sumatriptan Succinate Segment by Company

Teva
Merck
Mylan
Pfizer
Sun Pharmaceutical
GlaxoSmithKline
Endo Pharmaceuticals

Sumatriptan Succinate Segment by Type

Tablet
Subcutaneous Injection
Nasal Spray

Sumatriptan Succinate Segment by Application

Hospital Pharmacies
Drug Stores

Sumatriptan Succinate Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sumatriptan Succinate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sumatriptan Succinate and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sumatriptan Succinate.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Sumatriptan Succinate market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sumatriptan Succinate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Sumatriptan Succinate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Sumatriptan Succinate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Sumatriptan Succinate Market Size, 2020 VS 2024 VS 2031
1.3 Global Sumatriptan Succinate Market Size Estimates and Forecasts (2020-2031)
1.4 Global Sumatriptan Succinate Sales Estimates and Forecasts (2020-2031)
1.5 Global Sumatriptan Succinate Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Sumatriptan Succinate Market Dynamics
2.1 Sumatriptan Succinate Industry Trends
2.2 Sumatriptan Succinate Industry Drivers
2.3 Sumatriptan Succinate Industry Opportunities and Challenges
2.4 Sumatriptan Succinate Industry Restraints
3 Sumatriptan Succinate Market by Manufacturers
3.1 Global Sumatriptan Succinate Revenue by Manufacturers (2020-2025)
3.2 Global Sumatriptan Succinate Sales by Manufacturers (2020-2025)
3.3 Global Sumatriptan Succinate Average Sales Price by Manufacturers (2020-2025)
3.4 Global Sumatriptan Succinate Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Sumatriptan Succinate Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Sumatriptan Succinate Manufacturers, Product Type & Application
3.7 Global Sumatriptan Succinate Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Sumatriptan Succinate Market CR5 and HHI
3.8.2 Global Top 5 and 10 Sumatriptan Succinate Players Market Share by Revenue in 2024
3.8.3 2024 Sumatriptan Succinate Tier 1, Tier 2, and Tier 3
4 Sumatriptan Succinate Market by Type
4.1 Sumatriptan Succinate Type Introduction
4.1.1 Tablet
4.1.2 Subcutaneous Injection
4.1.3 Nasal Spray
4.2 Global Sumatriptan Succinate Sales by Type
4.2.1 Global Sumatriptan Succinate Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Sumatriptan Succinate Sales by Type (2020-2031)
4.2.3 Global Sumatriptan Succinate Sales Market Share by Type (2020-2031)
4.3 Global Sumatriptan Succinate Revenue by Type
4.3.1 Global Sumatriptan Succinate Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Sumatriptan Succinate Revenue by Type (2020-2031)
4.3.3 Global Sumatriptan Succinate Revenue Market Share by Type (2020-2031)
5 Sumatriptan Succinate Market by Application
5.1 Sumatriptan Succinate Application Introduction
5.1.1 Hospital Pharmacies
5.1.2 Drug Stores
5.2 Global Sumatriptan Succinate Sales by Application
5.2.1 Global Sumatriptan Succinate Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Sumatriptan Succinate Sales by Application (2020-2031)
5.2.3 Global Sumatriptan Succinate Sales Market Share by Application (2020-2031)
5.3 Global Sumatriptan Succinate Revenue by Application
5.3.1 Global Sumatriptan Succinate Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Sumatriptan Succinate Revenue by Application (2020-2031)
5.3.3 Global Sumatriptan Succinate Revenue Market Share by Application (2020-2031)
6 Global Sumatriptan Succinate Sales by Region
6.1 Global Sumatriptan Succinate Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Sumatriptan Succinate Sales by Region (2020-2031)
6.2.1 Global Sumatriptan Succinate Sales by Region (2020-2025)
6.2.2 Global Sumatriptan Succinate Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Sumatriptan Succinate Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Sumatriptan Succinate Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Sumatriptan Succinate Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Sumatriptan Succinate Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Sumatriptan Succinate Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Sumatriptan Succinate Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Sumatriptan Succinate Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Sumatriptan Succinate Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Sumatriptan Succinate Revenue by Region
7.1 Global Sumatriptan Succinate Revenue by Region
7.1.1 Global Sumatriptan Succinate Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Sumatriptan Succinate Revenue by Region (2020-2025)
7.1.3 Global Sumatriptan Succinate Revenue by Region (2026-2031)
7.1.4 Global Sumatriptan Succinate Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Sumatriptan Succinate Revenue (2020-2031)
7.2.2 North America Sumatriptan Succinate Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Sumatriptan Succinate Revenue (2020-2031)
7.3.2 Europe Sumatriptan Succinate Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Sumatriptan Succinate Revenue (2020-2031)
7.4.2 Asia-Pacific Sumatriptan Succinate Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Sumatriptan Succinate Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Sumatriptan Succinate Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Teva
8.1.1 Teva Comapny Information
8.1.2 Teva Business Overview
8.1.3 Teva Sumatriptan Succinate Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Teva Sumatriptan Succinate Product Portfolio
8.1.5 Teva Recent Developments
8.2 Merck
8.2.1 Merck Comapny Information
8.2.2 Merck Business Overview
8.2.3 Merck Sumatriptan Succinate Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Merck Sumatriptan Succinate Product Portfolio
8.2.5 Merck Recent Developments
8.3 Mylan
8.3.1 Mylan Comapny Information
8.3.2 Mylan Business Overview
8.3.3 Mylan Sumatriptan Succinate Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Mylan Sumatriptan Succinate Product Portfolio
8.3.5 Mylan Recent Developments
8.4 Pfizer
8.4.1 Pfizer Comapny Information
8.4.2 Pfizer Business Overview
8.4.3 Pfizer Sumatriptan Succinate Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Pfizer Sumatriptan Succinate Product Portfolio
8.4.5 Pfizer Recent Developments
8.5 Sun Pharmaceutical
8.5.1 Sun Pharmaceutical Comapny Information
8.5.2 Sun Pharmaceutical Business Overview
8.5.3 Sun Pharmaceutical Sumatriptan Succinate Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Sun Pharmaceutical Sumatriptan Succinate Product Portfolio
8.5.5 Sun Pharmaceutical Recent Developments
8.6 GlaxoSmithKline
8.6.1 GlaxoSmithKline Comapny Information
8.6.2 GlaxoSmithKline Business Overview
8.6.3 GlaxoSmithKline Sumatriptan Succinate Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 GlaxoSmithKline Sumatriptan Succinate Product Portfolio
8.6.5 GlaxoSmithKline Recent Developments
8.7 Endo Pharmaceuticals
8.7.1 Endo Pharmaceuticals Comapny Information
8.7.2 Endo Pharmaceuticals Business Overview
8.7.3 Endo Pharmaceuticals Sumatriptan Succinate Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Endo Pharmaceuticals Sumatriptan Succinate Product Portfolio
8.7.5 Endo Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Sumatriptan Succinate Value Chain Analysis
9.1.1 Sumatriptan Succinate Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Sumatriptan Succinate Production Mode & Process
9.2 Sumatriptan Succinate Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Sumatriptan Succinate Distributors
9.2.3 Sumatriptan Succinate Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings